Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Ainos, Inc. AIMDW NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
31/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Ainos, Inc. (AIMDW) is a Biotechnology company in the Healthcare sector, currently trading at $0.10. It has a SharesGrow Score of 30/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Valuation: AIMDW trades at a trailing Price-to-Earnings (P/E) of -0.5 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.71.

Financials: revenue is $124,157, +106.5%/yr average growth. Net income is $15M (loss), growing at -1.9%/yr. Net profit margin is -11897% (negative). Gross margin is 82.9% (+43 pp trend).

Balance sheet: total debt is $11M against $8M equity (Debt-to-Equity (D/E) ratio 1.45, moderate). Current ratio is 1.06 (adequate). Debt-to-assets is 52.7%. Total assets: $21M.

SharesGrow 7-Criteria breakdown: Value 33/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 33/100 (Fail), Moat 50/100 (Partial), Future ?/100 (Fail), Income 10/100 (Fail).

AIMDW SharesGrow Score Overview

37/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 33/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 50/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — AIMDW

✗
VALUE Fail
33/100
AIMDW trades at a trailing Price-to-Earnings (P/E) of -0.5 (S&P 500 average ~25). Forward PEG 2.71 — overvalued. Trailing PEG 2.71. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
58/100
AIMDW: +106.5%/yr revenue is, -1.9%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
33/100
Balance sheet AIMDW: Debt-to-Equity (D/E) ratio 1.45 (moderate), Current ratio is 1.06 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
50/100
AIMDW: Gross margin is 82.9% (+43 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 50/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
AIMDW: Net profit margin is -11897%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.1008-0.17
Volume368
Avg Volume (30D)4.95K
Market Cap$431.55K
Beta (1Y)-0.88
Share Statistics
EPS (TTM)-3.46
Shares Outstanding$4.27M
IPO Date2021-01-08
Employees44
CEOChun-Hsien Tsai
Financial Highlights & Ratios
Revenue (TTM)$124.16K
Gross Profit$102.91K
EBITDA$-9.28M
Net Income$-14.77M
Operating Income$-13.99M
Total Cash$417.35K
Total Debt$11M
Net Debt$10.58M
Total Assets$20.87M
Price / Earnings (P/E)-0
Price / Sales (P/S)3.48
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS00902F1131

Price Chart

Track all markets on TradingView
AIMDW
Ainos, Inc. ↗  ·  NASDAQ Global Market
Healthcare • Biotechnology
0.10 52WK RANGE 0.17

People Also View

REVB
REVB
Revelation Biosciences, Inc.
$1.20
+0.84%
 ZLDAF
ZLDAF
Zelira Therapeutics Limited
$0.33
+0.00%
 AZTR
AZTR
Azitra, Inc.
$0.22
+1.41%
 APLIF
APLIF
Appili Therapeutics Inc.
$0.01
+0.00%
 CDT
CDT
CDT Equity Inc.
$4.77
-4.22%
 VRAX
VRAX
Virax Biolabs Group Limited
$0.15
-9.98%
 WINT
WINT
Windtree Therapeutics, Inc.
$0.02
+65.45%
 BCTXZ
BCTXZ
BriaCell Therapeutics Corp. Warrant
$0.13
-8.06%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message